clinical trial · NCT06985147
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Polycythemia Vera (PV)DISC-3405
brief summary
This open-label, multicenter, within-participant dose escalation study examining up to 2 dose levels of DISC-3405 will assess the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of DISC-3405 in participants with polycythemia vera (PV).
started
Aug 12, 2025
primary completion
Feb 1, 2027
completion
Feb 1, 2029
last updated
Mar 4, 2026
official title
A Phase 2, Open-Label Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DISC-3405 in Participants With Polycythemia Vera (PV)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol